- Home
- CELZ vs GLMD Comparison
CELZ vs GLMD Comparison
Compare CELZ & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- GLMD
- Stock Information
- Founded
- CELZ 1998
- GLMD 2000
- Country
- CELZ United States
- GLMD Israel
- Employees
- CELZ N/A
- GLMD N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- GLMD Health Care
- Exchange
- CELZ Nasdaq
- GLMD Nasdaq
- Market Cap
- CELZ 5.5M
- GLMD 4.5M
- IPO Year
- CELZ N/A
- GLMD 2014
- Fundamental
- Price
- CELZ $2.29
- GLMD $1.46
- Analyst Decision
- CELZ
- GLMD
- Analyst Count
- CELZ 0
- GLMD 0
- Target Price
- CELZ N/A
- GLMD N/A
- AVG Volume (30 Days)
- CELZ 140.2K
- GLMD 2.6M
- Earning Date
- CELZ 05-09-2025
- GLMD 04-07-2025
- Dividend Yield
- CELZ N/A
- GLMD N/A
- EPS Growth
- CELZ N/A
- GLMD N/A
- EPS
- CELZ N/A
- GLMD N/A
- Revenue
- CELZ $11,000.00
- GLMD N/A
- Revenue This Year
- CELZ N/A
- GLMD N/A
- Revenue Next Year
- CELZ N/A
- GLMD N/A
- P/E Ratio
- CELZ N/A
- GLMD N/A
- Revenue Growth
- CELZ 22.22
- GLMD N/A
- 52 Week Low
- CELZ $1.92
- GLMD $1.33
- 52 Week High
- CELZ $6.90
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- CELZ 32.75
- GLMD 33.83
- Support Level
- CELZ $1.95
- GLMD $1.33
- Resistance Level
- CELZ $2.24
- GLMD $1.55
- Average True Range (ATR)
- CELZ 0.33
- GLMD 0.33
- MACD
- CELZ -0.07
- GLMD -0.04
- Stochastic Oscillator
- CELZ 5.63
- GLMD 6.83
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.